In a study targeting EGFR and HER2 in a bladder cancer model in immunodeficient mice, increases of ALT, AST, and BUN were observed, similarly to our results [42], but there was no evidence of damage in H&E sections of the liver and kidneys. Here, EGFR is linked to urinary bladder cancer.